Inuvo (INUV) Cash & Equivalents (2010 - 2025)

Inuvo (INUV) has reported Cash & Equivalents for 12 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 15.48% year-over-year to $2.8 million in Q4 2025; TTM through Dec 2025 was $2.8 million, a 15.48% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 15.48% from the prior year.
• Cash & Equivalents was $2.8 million for Q4 2025 at Inuvo, down from $3.4 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $17.8 million in Q1 2021 and troughed at $2.0 million in Q1 2023.
• A 5-year average of $5.8 million and a median of $3.9 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 3681.87% in 2021 and slumped 72.02% in 2022, its largest moves.
• Over 5 years, Cash & Equivalents stood at $10.5 million in 2021, then tumbled by 72.02% to $2.9 million in 2022, then jumped by 51.48% to $4.4 million in 2023, then tumbled by 44.62% to $2.5 million in 2024, then increased by 15.48% to $2.8 million in 2025.
• The last three Cash & Equivalents figures came in at $2.8 million (Q4 2025), $3.4 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.